Singapore markets closed

XBiotech Inc (4XB.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
7.35-0.35 (-4.55%)
At close: 08:08PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
8,210
0
4,010
18,394
43,997
Cost of revenue
1,681
0
651
5,820
34,548
Gross profit
6,529
0
3,359
12,574
9,449
Operating expenses
Research development
33,009
32,848
31,544
28,268
9,527
Selling general and administrative
7,042
4,662
6,305
9,388
18,198
Total operating expenses
40,051
37,510
37,849
37,656
27,725
Operating income or loss
-33,522
-37,510
-34,490
-25,082
-18,276
Total other income/expenses net
-6,570
2,776
-2,921
-843
2,993
Income before tax
-38,631
-24,313
-33,588
-25,458
-12,827
Income tax expense
-2,467
244
-688
-8,044
-1,606
Income from continuing operations
-36,164
-24,557
-32,900
-17,414
-11,221
Net income
-36,164
-24,557
-32,900
-17,414
-11,221
Net income available to common shareholders
-36,164
-24,557
-32,900
-17,414
-11,221
Basic EPS
-0.75
-
-1.08
-0.58
-0.36
Diluted EPS
-0.75
-
-1.08
-0.58
-0.36
Basic average shares
30,438
-
30,439
30,043
30,823
Diluted average shares
30,438
-
30,439
30,043
30,823